Consistent with the view that inhibiting the methylase of tRNA may lead to chemotherapy resistance, silencing other tRNA methyltransferases, such as m7G methylase METTL1, will undergo methylation modification on several tRNA variable loops, which can enhance the sensitivity of cancer cells to 5-FU (Okamoto et al., 2014). The gene discussed is METTL1; the disease is cancer.